Akademisyen profili · PROFESÖR
MEHMET ARTAÇ
NECMETTİN ERBAKAN ÜNİVERSİTESİ
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
37
Q2
37
Q3
54
Q4
11
WoS (JCR)
Q1
21
Q2
19
Q3
34
Q4
61
TR Index
19
makale
Makaleler
- 2025 Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy
- 2025 Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program
- 2025 The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study
- 2025 Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study
- 2025 Small cell lung cancer differentiation in patients with driver mutant non-small cell lung cancer: a single center experience
- 2025 Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report
- 2025 Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with Erlotinib
- 2025 Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study
- 2025 Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
- 2025 A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer
- 2025 Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy
- 2025 Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer
- 2025 Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
- 2025 Impact of Body Composition on Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Ribociclib
- 2025 Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
- 2025 Artificial intelligence and patient narratives: A novel approach to assessing hope in patients with cancer
- 2024 Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome
- 2024 Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
- 2024 Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study
- 2024 Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study